Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer

Guardado en:

Detalles Bibliográficos
Autores principales:	Mai F. Tolba, Cesar A. Santa-Maria, Adriana Albini, Emile R. Chimusa, Basel K. Al-Ramadi, Sara M. Tolaney
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	immunotherapy breast cancer immune checkpoint inhibitors combination therapy biomarker Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/c941230005bc480e9524d9065aec0e9e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c941230005bc480e9524d9065aec0e9e
record_format	dspace
spelling	oai:doaj.org-article:c941230005bc480e9524d9065aec0e9e2021-11-30T16:11:31ZEditorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer2234-943X10.3389/fonc.2021.752689https://doaj.org/article/c941230005bc480e9524d9065aec0e9e2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.752689/fullhttps://doaj.org/toc/2234-943XMai F. TolbaMai F. TolbaCesar A. Santa-MariaAdriana AlbiniEmile R. ChimusaBasel K. Al-RamadiBasel K. Al-RamadiSara M. TolaneySara M. TolaneyFrontiers Media S.A.articleimmunotherapybreast cancerimmune checkpoint inhibitorscombination therapybiomarkerNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	immunotherapy breast cancer immune checkpoint inhibitors combination therapy biomarker Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	immunotherapy breast cancer immune checkpoint inhibitors combination therapy biomarker Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Mai F. Tolba Mai F. Tolba Cesar A. Santa-Maria Adriana Albini Emile R. Chimusa Basel K. Al-Ramadi Basel K. Al-Ramadi Sara M. Tolaney Sara M. Tolaney Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
format	article
author	Mai F. Tolba Mai F. Tolba Cesar A. Santa-Maria Adriana Albini Emile R. Chimusa Basel K. Al-Ramadi Basel K. Al-Ramadi Sara M. Tolaney Sara M. Tolaney
author_facet	Mai F. Tolba Mai F. Tolba Cesar A. Santa-Maria Adriana Albini Emile R. Chimusa Basel K. Al-Ramadi Basel K. Al-Ramadi Sara M. Tolaney Sara M. Tolaney
author_sort	Mai F. Tolba
title	Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
title_short	Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
title_full	Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
title_fullStr	Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
title_full_unstemmed	Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
title_sort	editorial: immunotherapy as an evolving approach for the treatment of breast cancer
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/c941230005bc480e9524d9065aec0e9e
work_keys_str_mv	AT maiftolba editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer AT maiftolba editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer AT cesarasantamaria editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer AT adrianaalbini editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer AT emilerchimusa editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer AT baselkalramadi editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer AT baselkalramadi editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer AT saramtolaney editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer AT saramtolaney editorialimmunotherapyasanevolvingapproachforthetreatmentofbreastcancer
_version_	1718406471098564608

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer

Ejemplares similares